Skip to content

News & Events

Academic Thoracic Oncology Medical Investigators Consortium (ATOMIC)

Explore ATOMIC

ATOMIC Home
Institutions & Investigators
About
Facts

Explore Oncology Consortia

GI Cancer (AGICC)
Myeloma (AMyC)
Breast Cancer (ABRCC)
GU Cancer (AURIC)
Dr. D. Ross Camidge and Dr. Peter Kabos Win University of Colorado Recognition Awards
Dr. Peter Kabos, MD, Associate Professor, Division of Medical Oncology and Dr. D. Ross Camidge, MD, PhD, Professor of Medicine/Oncology were recently honored by the University of Colorado’s Division of Medical Oncology.
ATOMIC Investigators Meeting – Investigators Meet at IASLC For the First Time Since Covid
ATOMIC (Academic Thoracic Oncology Medical Investigators Consortium), met at the IASLC 2023 Targeted Therapies of Lung Cancer symposium in February in Santa Monica.
International Thoracic Oncology Experts – ESMO Panel Discussion
ATOMIC Director Ross Camidge MD, PhD, draws out novel opinions across the field of thoracic oncology from a panel of international experts discussing their favorite ESMO abstracts from 2022.
Industry News: Brain MRI surveillance needed for TKl-treated ALK or ROS7-positive NSCLC
Retrospective data showed how common central nervous system metastases are among patients with non-small cell lung cancer and ALK or ROS1 alterations who have been treated with tyrosine kinase inhibitors.
PharmaVoice Interview with Dr. D. Ross Camidge, Director of the Academic Thoracic Oncology Medical Investigators Consortium (ATOMIC)
Watch the PharmaVoice One on One video interview below to learn more about the latest in Thoracic Oncology research from Dr. D. Ross Camidge, Director of the Academic Thoracic Oncology Medical Investigators Consortium and Director of Thoracic Oncology at the University of Colorado.
« Prev12Next »